PATENT CLAIM ANALYSIS

Application Number: 15754414
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "416000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d 90 ) ranging from 1 μm to 100 μm.

Claim (Index 25):
The oral solid pharmaceutical composition according to  claim 14 , wherein the one or more disintegrant(s) are selected from croscarmellose, calcium carboxymethylcellulose, sodium starch glycolate, maize starch, pregelatinized starch, potato starch, alginic acid, polyvinylpyrrolidone (crospovidone) and low substituted hydroxypropyl cellulose (L-HPC).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14780495', '15852125', '11776012', '15387317', '13736699']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7364710109959652
- 35 USC 102 Novelty (BERT): 0.496740461207192
- Combined Prediction Score: 0.712497956017088
- Mean Citation Score: 200.706194
- Max Citation Score: 204.72156
- Similarity Product: 146.67907756234646

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test